DisperSol Employee Directory

DisperSol corporate office is located in 111 Cooperative Way Bldg 2-200, Georgetown, Texas, 78626, United States and has 11-50 employees.

Employees by Department

Departments

Number of employees

Engineering & Technical

2

Operations

1

C-Suite

1

Finance

1

Key Employees of DisperSol

  • Christopher Brough, Chief Technology Officer at DisperSol
    United States flag for contact location.
    Christopher Br...

    Chief Technology Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

DisperSol Global Presence

globalPresence illustration
North America1-10

Index of contact profiles from DisperSol

Hundreds of professionals searching for DisperSol have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at DisperSol

Explore people who held key positions, contributed to DisperSol's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in Texas, United States

Frequently Asked Questions Regarding DisperSol Employees

How many employees does DisperSol have?
DisperSol has 11-50 employees
Who is the CFO of DisperSol?
DisperSol’s CFO is Francesco Sherod
Who are DisperSol key employees?
Some of DisperSol key employees are Christopher Brough
Where is DisperSol located?
DisperSol’s headquarters are located at 111 Cooperative Way Bldg 2-200, Georgetown, Texas, 78626, United States
How do I contact DisperSol?
DisperSol Contact Info: Phone number: (512) 686-4740 Website: www.dispersoltech.com
What does DisperSol do?

DisperSol is a clinical-stage drug development company focused on developing new treatments for patients utilizing its proprietary KinetiSol® technology platform. KinetiSol has proven capable of creating novel therapeutics from poorly bioavailable drugs to deliver unique clinical benefits to patients. The platform enables a drug development path fo... rward to patients when other options fail to make a difference. DisperSol's active programs include, DST-0509 about to enter Phase 3 for iron overload disorder and DST-2970 in Phase 2 for refractory metastatic prostate cancer. Additional earlier-stage programs include DST-5407 for non-squamous non-small cell lung cancer.Read More

Is DisperSol a public company?
DisperSol is private company therefore does not currently have an official ticker symbol
See more information about DisperSol Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.